BRIEF

on NOVACYT (EPA:ALNOV)

Publication of the annual report of Novacyt SA

Novacyt SA, an international molecular diagnostics company, announced the publication of its annual report for the financial year ended December 31, 2023. This document is now available on the company's website.

Shareholders holding common stock through CREST Depository Interests (CDI) will also receive a copy of the report.

Novacyt continues to expand its portfolio of integrated technologies and services across various sectors, including human health, animal health and environment, with a strong global presence.

R. P.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all NOVACYT news